Skip to main content

Amiodarone-Associated Optic Neuropathy

  • Chapter
  • First Online:

Abstract

A 56-year-old male presented with complaints of gradual blurring in his left eye for 2 months. He was diagnosed with anterior ischemic optic neuropathy and referred to our department. The referring note cited a lower altitudinal defect in the left eye as of 3 weeks ago. The patient did not have a medical history of diabetes or hypertension, but did suffer from cardiac arrhythmias which were controlled under regular amiodarone treatment. No history of alcohol drinking or cigarette smoking was noted. Ophthalmoscopic examination showed a visual acuity of 6/6 in the right eye and 6/10 in the left. He could identify 15 plates in the right eye and only 4 plates in the left eye with the Ishihara test. Intraocular pressure was normal. Corneal verticillata was noted in both eyes. The anterior chambers were quiet and the lens was clear OU. A mild relative afferent pupillary defect was found in the left eye. Pale swelling of the left optic disc was found in the left fundus (Fig. 12.1). Fluorescein angiography revealed hypoperfusion of the upper disc OS in early phase and dye staining on left disc at late phase (Fig. 12.2), which is compatible with anterior ischemic optic neuropathy. A visual field test showed a constricted field associating with inferior cecocentral scotoma in the left eye (Fig. 12.3). Supportive treatment was given under the impression of anterior ischemic optic neuropathy. His vision deteriorated to 6/12 in the left eye with persistent disc edema 2 weeks later. Since the disc edema persisted for more than 3 months after onset, amiodarone was discontinued under his medical doctor’s supervision under the impression of suspected amiodarone-associated optic neuropathy. Six weeks later, his left vision recovered to 6/8.6 with marked resolution of disc edema (Fig. 12.4). His visual acuity recovered to 6/6 in the left eye 1 year later. His visual field improved partially after long-term follow-up (Fig. 12.5).

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Murphy MA, Murphy JF. Amiodarone and optic neuropathy: the heart of the matter. J Neuro-Ophthalmol. 2005;25:232–6.

    Article  Google Scholar 

  2. Vassallo P, Trohman RG. Prescribing amiodarone: an evidence-based review of clinical indications. JAMA. 2007;298:1312–22.

    Article  CAS  Google Scholar 

  3. Ingram DV, Jaggarao NS, Chamberlain DA. Ocular changes resulting from therapy with amiodarone. Br J Ophthalmol. 1982;66(10):676–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Mantyjarvi M, Tuppurainen K, Ikaheimo K. Ocular side effects of amiodarone. Surv Ophthalmol. 1998;42:360–6.

    Article  CAS  PubMed  Google Scholar 

  5. Johnson LN, Krohel GB, Thomas ER. The clinical spectrum of amiodarone-associated optic neuropathy. J Natl Med Assoc. 2004;96(11):1477–91.

    Google Scholar 

  6. Flach AJ, Dolan BJ. Amiodarone-induced lens opacities: an 8-year follow-up study. Arch Ophthalmol. 1990;108:1668–9.

    Article  CAS  PubMed  Google Scholar 

  7. Younge BR. Amiodarone and ischemic optic neuropathy. J Neuro-Ophthalmol. 2007;27:85–6.

    Article  Google Scholar 

  8. Mindel JS. Amiodarone and optic neuropathy. Am Heart J. 2008;156:411–3.

    Article  PubMed  Google Scholar 

  9. Hayreh SS. Amiodarone, erectile dysfunction drugs, and non-arteritic ischemic optic neuropathy. J Neuro-Ophthalmol. 2006;26:154–5.

    Article  Google Scholar 

  10. Cheng HC, Yeh HJ, Huang N, Chou YJ, Yen MY, Wang AG. Amiodarone-associated optic neuropathy: a nationwide study. Ophthalmology. 2015;122(12):2553–9.

    Article  PubMed  Google Scholar 

  11. Passman RS, Bennett CL, Purpura JM, Kapur R, Johnson LN, Raisch DW, West DP, Edwards BJ, Belknap SM, Liebling DB, Fisher MJ, Samaras AT, Jones LG, Tulas KM, McKoy JM. Amiodarone-associated optic neuropathy: a critical review. Am J Med. 2012;125(5):447–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Macaluso DC, Shut WT, Fraunfelder FT. Features of amiodarone-induced optic neuropathy. Am J Ophthalmol. 1999;127:610–2.

    Article  CAS  PubMed  Google Scholar 

  13. Nagra PK, Foroozan R, Savino PJ, Castillo I, Sergott RC. Amiodarone induced optic neuropathy. Br J Ophthalmol. 2003;87:420–2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Latini R, Tognoni G, Kates RE. Clinical pharmacokinetics of amiodarone. Clin Pharmacokinet. 1984;9:136–56.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Wang, AG. (2018). Amiodarone-Associated Optic Neuropathy. In: Emergency Neuro-ophthalmology . Springer, Singapore. https://doi.org/10.1007/978-981-10-7668-8_12

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-7668-8_12

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-7667-1

  • Online ISBN: 978-981-10-7668-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics